DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09

NovoCare

Novo Nordisk’s direct channel: injectable Wegovy at $349/month standard cash ($199 two-month intro at starter doses) and the oral Wegovy pill from $149 — the approved-semaglutide floor that has compressed the compounded discount to double digits at the low end.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

Seen against the live index: with verified all-in prices spanning $215 to $597 for tirzepatide and $133 to $348 for semaglutide as of 2026-08-09, terms like this one are not pedantry — they are the difference between the advertised number and the billed one. Every definition in this glossary links back to the places in the database and the methodology where the concept does its work.

Its $149 oral floor is the single number that most reshaped the semaglutide comparison this year. Related figures live on the pages this term links to, and every one of them regenerates from the same dataset this definition does.

See the term in action across the price database and the methodology.

All-in priceMaintenance-dose basisDose-flat pricingDose-tiered pricingMembership feePrepaid term